This inventor holds 13 USPTO granted patents and 7 published patent applications and 1 EPO patent. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, Nanosomix, Inc., Temple University. Active years: 2015-2025.
Company Filing History:
4 out of 3,690 
3 out of 5 
1 out of 423 
Years Active: 2015-2025
Title: Edward J Goetzl: Innovator in Neurodegenerative Disorders
Introduction
Edward J Goetzl is a prominent inventor based in San Francisco, CA (US). He has made significant contributions to the field of neurodegenerative disorders, holding a total of 13 patents. His work focuses on developing diagnostic and therapeutic methods for conditions such as depression, psychosis, schizophrenia, and Alzheimer's disease.
Latest Patents
Goetzl's latest patents include innovative approaches to understanding and treating mental health conditions. One of his notable inventions is the "Exosome assay for depression and psychosis and methods and agents for treating depression, psychosis and schizophrenia." This patent discusses exosomal complement mediators, cytokines, and mitochondrial electron transport biomarkers, providing diagnostic and prognostic methods for these mental health issues. Additionally, he has developed biomarkers and diagnostic methods for Alzheimer's disease and other neurodegenerative disorders, offering compositions for detecting these biomarkers and methods for treatment.
Career Highlights
Throughout his career, Edward J Goetzl has worked with esteemed organizations, including the National Institutes of Health, a component of the US Department of Health & Human Services. His research has significantly advanced the understanding of neurodegenerative diseases and their treatment.
Collaborations
Goetzl has collaborated with notable colleagues such as Weiming Luo and David Tweedie, contributing to the advancement of research in his field.
Conclusion
Edward J Goetzl's innovative work in the realm of neurodegenerative disorders has led to significant advancements in diagnostics and treatment. His contributions continue to impact the field positively, showcasing the importance of research and innovation in addressing complex health issues.